SCHEMBL27606911

SCHEMBL27606911

CC(C)c1ccc(Nc2ccncn2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 9/20 0.47
▸ NFKB1 P19838 1/20 0.45
▸ MKNK2 Q9HBH9 2/20 0.44
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CCNA2 P20248 1/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ CCNA1 P78396 1/20 0.42
▸ MAPKAPK2 P49137 1/20 0.41
▸ KDR P35968 1/20 0.40
▸ MPL P40238 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4666187 0.80 RAD52 (0.59) MKNK1MKNK2NPC1RAB9AALDH1A1
SCHEMBL14843891 0.79 MKNK1 (0.49) MKNK1MKNK2KDRMPL
SCHEMBL4988484 0.77 MKNK1 (0.39) MKNK1MKNK2CCNA2CDK2CCNA1
SCHEMBL2793375 0.77 NPC1 (0.54) NFKB1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL30611577 0.77 MEN1 (0.56) MKNK1MKNK2NPC1RAB9AALDH1A1
SCHEMBL29134221 0.77 NFKB1 (0.58) NFKB1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL23867504 0.76 RAB9A (0.46) MKNK1MKNK2NPC1RAB9ASMN1; SMN2
SCHEMBL10033201 0.76 MKNK1 (0.44) MKNK1MKNK2KDRMPL
SCHEMBL30062475 0.76 MEN1 (0.67) NPC1RAB9ASMN1; SMN2ALDH1A1MEN1
SCHEMBL2789615 0.76 RAB9A (0.64) NFKB1NPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1625400-A 2, 4-pyrimidinediamine compounds and uses thereof RIGEL PHARMACEUTICALS INC (US) 2005-06-08 — — CN disclosed
Send feedback